Portland Global Advisors LLC reduced its stake in Xylem Inc. (NYSE:XYL) by 5.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,025 shares of the company’s stock after selling 550 shares during the period. Portland Global Advisors LLC’s holdings in Xylem were worth $403,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of XYL. Norges Bank acquired a new stake in Xylem during the fourth quarter valued at $130,301,000. Chevy Chase Trust Holdings Inc. increased its stake in Xylem by 4.1% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 150,902 shares of the company’s stock valued at $6,172,000 after buying an additional 5,995 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its stake in Xylem by 10.8% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 42,417 shares of the company’s stock valued at $1,735,000 after buying an additional 4,142 shares in the last quarter. Exxonmobil Investment Management Inc. TX increased its stake in Xylem by 8.1% in the first quarter. Exxonmobil Investment Management Inc. TX now owns 43,457 shares of the company’s stock valued at $1,777,000 after buying an additional 3,254 shares in the last quarter. Finally, PGGM Investments acquired a new stake in Xylem during the first quarter valued at $12,327,000. 84.69% of the stock is owned by institutional investors and hedge funds.

Shares of Xylem Inc. (NYSE:XYL) traded up 1.56% during midday trading on Thursday, reaching $52.62. 1,042,892 shares of the company’s stock were exchanged. The company has a market cap of $9.43 billion, a price-to-earnings ratio of 28.09 and a beta of 1.15. The stock’s 50 day moving average price is $49.85 and its 200 day moving average price is $45.04. Xylem Inc. has a 12-month low of $31.27 and a 12-month high of $52.68.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $0.48 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.01. Xylem had a net margin of 9.22% and a return on equity of 16.41%. The business earned $932 million during the quarter, compared to analyst estimates of $927.69 million. During the same quarter last year, the business earned $0.43 earnings per share. Xylem’s quarterly revenue was up 1.3% compared to the same quarter last year. Equities analysts anticipate that Xylem Inc. will post $2.04 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 21st. Stockholders of record on Wednesday, August 31st were issued a $0.1549 dividend. The ex-dividend date of this dividend was Monday, August 29th. This represents a $0.62 annualized dividend and a dividend yield of 1.18%. Xylem’s dividend payout ratio (DPR) is presently 33.16%.

A number of equities analysts have issued reports on the stock. Royal Bank Of Canada upgraded shares of Xylem from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $37.00 to $42.00 in a research report on Wednesday, June 1st. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $52.00 price objective (up previously from $46.00) on shares of Xylem in a research report on Monday, June 20th. Zacks Investment Research cut shares of Xylem from a “buy” rating to a “hold” rating in a research report on Friday, July 15th. Barclays PLC boosted their price objective on shares of Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a research report on Monday, July 18th. Finally, RBC Capital Markets set a $51.00 price objective on shares of Xylem and gave the company a “buy” rating in a research report on Tuesday, August 16th. Nine investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $45.00.

In other news, Director Steven R. Loranger sold 33,887 shares of the firm’s stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $48.11, for a total value of $1,630,303.57. Following the completion of the sale, the director now owns 11,243 shares in the company, valued at approximately $540,900.73. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Colin R. Sabol sold 27,473 shares of the firm’s stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $50.91, for a total transaction of $1,398,650.43. Following the completion of the sale, the insider now owns 65,530 shares of the company’s stock, valued at approximately $3,336,132.30. The disclosure for this sale can be found here. 0.77% of the stock is currently owned by insiders.

Xylem Company Profile

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.